News
Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICMLPresentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June ...
When Miranda Aldridge first noticed a tiny bump near her daughter Cameron’s eye, it didn’t seem alarming, just unusual. But ...
17h
Zacks Investment Research on MSNSanofi Signs a $9.5B Agreement to Acquire Blueprint MedicinesSanofi SNY announced that it has entered into a definitive agreement to acquire Blueprint Medicines BPMC for a total deal ...
University of South Florida and Tampa General Hospital Cancer Institute launch the “Microbial Oncogenesis and Cancer Therapy” ...
Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by ...
Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...
Bristol Myers Squibb partners with BioNTech in a $11.1B deal to develop BNT327, a promising cancer immunotherapy. Read more ...
17h
Pharmaceutical Technology on MSNBMS outlays $11bn to join BioNTech’s development of bispecific cancer drugThe deal will see BMS partner with BioNTech on a bispecific antibody candidate, dubbed BNT327, of which the latter company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results